This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Vaginitis Treatment Drugs Market

Market Insights on Vaginitis Treatment Drugs covering sales outlook, demand forecast & up-to-date key trends

Vaginitis Treatment Drugs Market By Drug Type, Indication, Route of Administration, Schedule of Drug, Distribution Channel & Region - Forecast 2022-2030

Vaginitis Treatment Drugs Market Outlook (2022-2030)

[250 Pages Report] The global vaginitis treatment drugs market is likely to be valued at around US$ 3.01 Bn in 2022. Market growth is expected to progress at 5.2% CAGR to reach US$ 4.52 Bn by the end of 2030.

Vaginitis Treatment Drugs Market Size (2022)

US$ 3.01 Bn

Revenue Forecast (2030)

US$ 4.52 Bn

Global Market Growth Rate (2022-2030)

5.2% CAGR

Market Share of Nitroimidazole Compounds

43.4%

Vaginitis treatment drug consumption currently accounts for 7% share in the global antibiotics market. Some of the important reasons driving demand for vaginitis treatment drugs are increased knowledge about women's health, development of new pharmaceuticals by significant businesses, and rising desire for improved healthcare facilities.

Customize this Report

Let us know your requirement to get
100% FREE customization

Vaginitis Treatment Drug Demand Analysis (2015 to 2021) Vs Market Outlook (2022 to 2030)

Vaginitis is a vaginal irritation that causes discharge, itching, and pain. A change in the balance of vaginal flora or an infection is the most common cause. Vaginitis can be caused by low oestrogen levels after menopause, as well as some skin conditions.

Vaginitis can be caused by a variety of bacterial infections and circumstances, so treatment is based on the exact cause. Bacterial vaginitis, fungal vaginitis (yeast infection), and trichomoniasis are the most frequent kinds of vaginitis. Vaginitis can be treated with a variety of medications.

"Almost every nitroimidazole medicine given orally in a single dosage or over a long period leads to parasitological cure in 90% of instances. A single 2-g dose of metronidazole is sufficient, but it can cause dyspepsia and a metallic taste; compliant patients may choose a lengthier regimen with a lower daily dose and fewer side effects. Bacterial vaginosis and trichomoniasis can be treated with metronidazole at a dose of 500 mg twice weekly. Metronidazole-resistant strains should be treated with 2 to 4 g of metronidazole daily for a week or two," according to aafp.org.

The vaginitis treatment drugs market expanded at a CAGR of 4.2% from 2015 to 2021. The market is expected to grow due to an increase in R&D initiatives for precise diagnosis. Various government and non-government bodies, including the World Health Organization and the European Institute of Women's Health (EIWH), have launched public awareness campaigns about women's health.

The market is being driven by numerous firms' continuous R&D operations, as well as changing lifestyle patterns of women around the world, such as cigarette and alcohol intake.

Demand for vaginitis treatment drugs is expected to expand at a CAGR of 5.2% from 2022 to 2030, with the global market predicted to reach a valuation of US$ 4.52 Bn by 2030.

Vaginitis Treatment Drugs Market Download Report Brochure

Which Market Factors are Stimulating Demand for Vaginitis Treatment Drugs?

“Increased Incidence of Infectious Vaginosis and Rising R&D Activities & Public Awareness about Women's Health”

According to University of Cape Town researchers, a vaginal health probiotic including vaginal lactobacillus strains may be a better therapy choice for vaginitis.

This probiotic may also reduce the incidence of STDs and bad pregnancy outcomes, according to the researchers. On these grounds, more expenditure on research in the vaginitis treatment drugs market is expected throughout the forecast period.

Furthermore, expanding healthcare infrastructure in developing economies, availability of pharmaceutical drugs, and robust technological advancements in the biopharmaceutical industries are all contributing to significant opportunities for vaginitis treatment drugs over the forecasted period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Can Negatively Influence Sales of Vaginitis Treatment Drugs?

“Asymptomatic Nature of Bacterial Vaginitis & Unawareness of Vaginitis Diagnostic Tests Stunting Demand for Vaginitis Treatment Drugs

At least half of the female population can suffer from bacterial vaginosis (BV) with no symptoms. Even when asymptomatic, bacterial vaginosis is linked to a high prevalence of pelvic inflammatory illness and endometritis.

The asymptomatic form of vaginosis inhibits the populace from detecting the infection and taking early steps to prevent infection transmission. Antibiotic and antifungal medicine demand is predicted to be hampered by the increasing incidence of asymptomatic vaginitis.

Which Regional Markets are Lucrative for Manufacturers of Vaginitis Treatment Drugs?

“Developed Healthcare Facilities, High Incidence of Diseases, and Presence of Key Producers in North America Market”

The most profitable market for vaginitis treatment medications is North America. This region's established healthcare infrastructures, as well as the high frequency of disease and the presence of important manufacturers, are major factors contributing towards vaginitis treatment drugs market share.

As manufacturers develop novel vaginal tablets, Europe's vaginitis treatment drugs industry, which accounts for more than one-fourth of worldwide vaginitis treatment revenues, is poised to see lucrative development prospects in the future.

  • For example, Gedea created pHyph, a pill that helps restore vaginal acidity in the first instance.

Brazil and South Africa, in addition to these two lucrative markets, provide considerable prospects for vaginitis treatment drug manufacturers.

During the projection period, the Asia Pacific vaginitis treatment medication market is predicted to develop at the fastest rate. This is due to a significant number of unmet clinical requirements, improved knowledge of early diagnosis, and the availability of effective medications.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Analysis

How is the Market for Vaginitis Treatment Drugs Faring in the U.S.?

“Rising Number of Vaginitis Cases Driving Demand for OTC Drugs”

The overgrowth of microorganisms (lactobacillus) in the vaginal area upsets the natural balance. Around 33% of women in the United States are impacted by this excess growth, which leads to "Vaginitis."

If left untreated, vaginitis can lead to miscarriages, pre-term babies, and, most importantly, a 2X to 4X higher chance of contracting HIV. Other STDs linked to vaginitis include chlamydia, gonorrhoea, and papillomavirus. Also, infertility can occur at any time.

The aforementioned facts highlight the need for vaginitis treatment. The OTC drugs are also included in the vaginitis treatment drugs market. The novel approach for treating vaginitis is "vaginal bacteria transplants." As a result, the vaginitis treatment pharmaceuticals market is likely to experience a surge in innovation over the coming years.

Which Factors are Supporting Growth of the Vaginitis Treatment Medicines Market in India?

“Rising Awareness of Vaginitis & Availability of Advanced Treatment Aiding Sales of Vaginitis Treatment Drugs”

Vaginitis is a fast-spreading problem among women all over the world, and it is a growing concern in India too.

Bacterial vaginosis is the major cause of vaginitis in women of reproductive age, according to a study published on pathology.medresearch.in, "In the gynaecological outpatient environment, it is the most prevalent condition. In India, the incidence of bacterial vaginosis in adults ranges from 17.8 percent to 63.7 percent.

The report concludes that "Bacterial vaginosis was found to be prevalent in 44.6 percent of the population. For the diagnosis of bacterial vaginosis, Amsel's criteria were equivalent to Nugent's criteria, and are simple, quick, cost-effective, and trustworthy, and it may be used for precise and quick treatment too".

As a result of greater awareness regarding early detection of vaginitis and skin cancer, as well as the availability of efficient medications, vaginitis treatment drug sales in India are on the rise.

Category-wise Analysis     

Which Distribution Channel Will Be Profitable for Vaginitis Treatment Drug Suppliers?

“Online Pharma Portals Driving Drug Sales of Mail Order Pharmacies”

Hospital pharmacies, drug stores, and mail order pharmacies all contribute to the overall sales of vaginitis treatment drugs, which are dominated by retail pharmacies. The Covid-19 pandemic has resulted in a spike in drug sales by mail order pharmacies, which is projected to continue at a rapid pace in the coming years.

More patients are getting their prescription drugs through the mail and various internet outlets. The online pharmacy sector of India witness more than 50 plus startups.

Which Drugs Provide the Most Effective Results for Vaginitis Treatment?

“Nitroimidazole Compounds Widely Used Due to Effective Results”

Nitroimidazole compounds account for more than half of the global market share for vaginitis treatment drugs. At present, nitroimidazole compounds are expected to account for 43.4% of the global market share. This could be due to their widespread use and availability, as well as the fact that they are the most widely approved form of vaginitis treatment.

Tinidazole and metronidazole are the most commonly recommended antibiotic compounds for vaginitis treatment. Furthermore, manufacturers have been concentrating on the introduction of novel pharmaceuticals as well as collaborations in this area. In 2022, triazoles and imidazoles are likely to hold 14% and 25.1% of the global market share respectively.

Lincosamide is an antibiotic that is used to treat infections caused by bacteria like pelvic inflammatory disease, stomach infections, abscesses, pimples, and anaerobic infectious diseases. They're typically used to treat serious infections in penicillin-allergic people. Lincosamide antibiotics are bacteriostatic drugs that limit bacterial multiplication by interacting with protein synthesis.

At high antibiotic doses, they may also have a bactericidal (killing) effect against pathogens. Currently, lincosamide antibiotics are predicted to account for 17.5% of the global market share.

Competitive Landscape

The vaginitis treatment drugs market is still largely consolidated. At the worldwide level, there is an influx of unique pharmaceuticals on the market. Competition is intense, with an additional 25+ vaginitis therapy drug players, medication development, clinical trials, and e-commerce.

Because vaginitis has a high recurrence rate, makers of vaginitis treatment drugs are concentrating on the development of non-antibiotic medications for long-term treatment.

Single-dose medications and over-the-counter drugs are being introduced by key companies, allowing for cost-effective treatment. Furthermore, manufacturers are concentrating on forming drug research alliances to expand the pool of more effective pharmaceutical prospects.

  • Lupin Pharmaceuticals announced a partnership with PlushCare to make bacterial vaginosis (BV) treatment easier via the PlushCare virtual platform.
  • TCM (Traditional Chinese Medicine) is being administered for treating vaginitis for the last several years. Research is being conducted for the development of more efficient antibiotics as resistance to TCM is springing up.
  • Patients can use PlushCare to schedule a virtual visit with a doctor, discuss their symptoms, and receive a prescription for lab testing.
  • In Poland, Bayer's Canesten moved from being an Rx to an OTC therapy for vaginal yeast infection. Clotrimazole, miconazole, and tioconazole are among the other medications that have gone over-the-counter.
  • Pfizer Inc. and Basilea Pharmaceutica Ltd. agreed to collaborate on the development and marketing of cresemba® (isavuconazole) in China and the Asia Pacific region.

Vaginitis Treatment Drugs Industry Report Scope

Attribute

Details

Forecast Period

2022-2030

Historical Data Available for

2015-2021

Market Analysis

US$ Bn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries

Key Market Segments Covered

  • Drug
  • Indication
  • Route of Administration
  • Schedule of Drug
  • Distribution Channel
  • Region

Key Companies Profiled

Pricing

Available upon Request

Key Segments of Vaginitis Treatment Drugs Industry Survey

Vaginitis Treatment Drugs Market by Drug:

  • Nitroimidazole Compounds
  • Lincosamide Antibiotics
  • Triazoles
  • Imidazoles

Vaginitis Treatment Drugs Market by Indication:

  • Bacterial Vaginitis
  • Fungal Vaginitis (Yeast Infection)
  • Trichomoniasis

Vaginitis Treatment Drugs Market by Route of Administration:

  • Oral Vaginitis Treatment Drugs
  • Cutaneous Vaginitis Treatment Drugs
  • Vaginal Vaginitis Treatment Drugs

Vaginitis Treatment Drugs Market by Schedule of Drug:

  • Prescription Vaginitis Treatment Drugs (Rx)
  • Over-the-counter Vaginitis Treatment Drugs (OTC)

Vaginitis Treatment Drugs Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Mail Order Pharmacies

Vaginitis Treatment Drugs Market by Region:

  • North America Vaginitis Treatment Drugs Market
  • Latin America Vaginitis Treatment Drugs Market
  • Europe Vaginitis Treatment Drugs Market
  • East Asia Vaginitis Treatment Drugs Market
  • South Asia & Pacific Vaginitis Treatment Drugs Market
  • Middle East & Africa (MEA) Vaginitis Treatment Drugs Market

Frequently Asked Questions

The global vaginitis treatment drugs market is expected to enjoy a valuation of US$ 3.01 Bn in 2022 and is anticipated to progress at a healthy CAGR of 5.2% to reach a valuation of US$ 4.52 Bn by 2030.

The global market for vaginitis treatment drugs progressed at a CAGR of 4.2% from 2015 to 2021.

Key manufacturers of vaginitis treatment drugs are Pfizer Inc., Mylan NV, Novartis AS, and Bayer AG.

Nitroimidazole compounds are likely to hold 43.4% of the global market share in 2022.

Increased knowledge of women's health, introduction of new medications by major pharmaceutical companies, and rising need for advanced healthcare facilities are all boosting market expansion.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Innovation / Development Trends

4. Market Context

    4.1. Regulatory Scenario

    4.2. Pipeline Analysis

    4.3. Reimbursement Scenario by Region

    4.4. Disease Epidemiology by Region

5. Market Background

    5.1. Macro-Economic Factors

    5.2. Forecast Factors - Relevance & Impact

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

    5.4. Value Chain Analysis

    5.5. COVID19 Crisis Analysis

        5.5.1. Current COVID19 Statistics and Probable Future Impact

        5.5.2. Current GDP Projection and Probable Impact

        5.5.3. Current Economic Projection as compared to 2008 Economic analysis

        5.5.4. COVID19 and Impact Analysis

            5.5.4.1. Revenue By Product

            5.5.4.2. Revenue By Country

        5.5.5. 2022 Market Scenario

        5.5.6. Quarter by Quarter Forecast

        5.5.7. Projected recovery Quarter

        5.5.8. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Global Vaginitis Treatment Drugs Market Demand (in Value or Size in US$ Mn) Analysis 2015-2021 and Forecast, 2022–2030

    6.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    6.2. Current and Future Market Value (US$ Mn) Projections, 2022–2030

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Absolute $ Opportunity Analysis

7. Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, by Drug Type

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2015-2021

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2022–2030

        7.3.1. Nitroimidazole Compound

        7.3.2. Lincosamide Antibiotics

        7.3.3. Triazoles

        7.3.4. Imidazoles

8. Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, by Indication

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast Indication, 2022 – 2030

        8.3.1. Bacterial Vaginitis

        8.3.2. Fungal Vaginitis (Yeast infection)

        8.3.3. Trichomoniasis

9. Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, by Route of Administration

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast Route of Administration, 2022 – 2030

        9.3.1. Oral

        9.3.2. Cutaneous

        9.3.3. Vaginal

10. Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, by Schedule of Drug

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Schedule of Drug, 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Schedule of Drug, 2022 – 2030

        10.3.1. Prescription Drugs (Rx)

        10.3.2. Over the counter Drugs (OTC)

11.  Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, by Distribution Channel

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 – 2030

        11.3.1. Hospital Pharmacies

        11.3.2. Retail Pharmacies

        11.3.3. Drug Stores

        11.3.4. Mail Order Pharmacy

12. Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2030

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Middle East & Africa

    12.4. Market Attractiveness Analysis By Region

13. North America Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030

        13.3.1. By Drug Type

        13.3.2. By Indication

        13.3.3. By Route of Administration

        13.3.4. By Schedule of Drug

        13.3.5. By Distribution Channel

        13.3.6. By Country

            13.3.6.1. U.S.

            13.3.6.2. Canada

    13.4. Market Attractiveness Analysis

        13.4.1. By Drug Type

        13.4.2. By Indication

        13.4.3. By Route of Administration

        13.4.4. By Schedule of Drug

        13.4.5. By Distribution Channel

        13.4.6. By Country

    13.5. Market Trends

14. Latin America Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030

        14.3.1. By Drug Type

        14.3.2. By Indication

        14.3.3. By Route of Administration

        14.3.4. By Schedule of Drug

        14.3.5. By Distribution Channel

        14.3.6. By Country

            14.3.6.1. Brazil

            14.3.6.2. Mexico

            14.3.6.3. Argentina

            14.3.6.4. Rest of Latin America

    14.4. Market Attractiveness Analysis

        14.4.1. By Drug Type

        14.4.2. By Indication

        14.4.3. By Route of Administration

        14.4.4. By Schedule of Drug

        14.4.5. By Distribution Channel

        14.4.6. By Country

    14.5. Market Trends

15. Europe Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030

        15.3.1. By Drug Type

        15.3.2. By Indication

        15.3.3. By Route of Administration

        15.3.4. By Schedule of Drug

        15.3.5. By Distribution Channel

        15.3.6. By Country

            15.3.6.1. Germany

            15.3.6.2. Italy

            15.3.6.3. France

            15.3.6.4. U.K.

            15.3.6.5. Spain

            15.3.6.6. Russia

            15.3.6.7. Rest of Europe

    15.4. Market Attractiveness Analysis

        15.4.1. By Drug Type

        15.4.2. By Indication

        15.4.3. By Route of Administration

        15.4.4. By Schedule of Drug

        15.4.5. By Distribution Channel

        15.4.6. By Country

    15.5. Market Trends

16. South Asia Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030

        16.3.1. By Drug Type

        16.3.2. By Indication

        16.3.3. By Route of Administration

        16.3.4. By Schedule of Drug

        16.3.5. By Distribution Channel

        16.3.6. By Country

            16.3.6.1. India

            16.3.6.2. Thailand

            16.3.6.3. Indonesia

            16.3.6.4. Malaysia

            16.3.6.5. Rest of South Asia

    16.4. Market Attractiveness Analysis

        16.4.1. By Drug Type

        16.4.2. By Indication

        16.4.3. By Route of Administration

        16.4.4. By Schedule of Drug

        16.4.5. By Distribution Channel

        16.4.6. By Country

    16.5. Market Trends

17. East Asia Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030

        17.3.1. By Drug Type

        17.3.2. By Indication

        17.3.3. By Route of Administration

        17.3.4. By Schedule of Drug

        17.3.5. By Distribution Channel

        17.3.6. By Country

            17.3.6.1. China

            17.3.6.2. Japan

            17.3.6.3. South Korea

    17.4. Market Attractiveness Analysis

        17.4.1. By Drug Type

        17.4.2. By Indication

        17.4.3. By Route of Administration

        17.4.4. By Schedule of Drug

        17.4.5. By Distribution Channel

        17.4.6. By Country

    17.5. Market Trends

18. Oceania Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030

        18.3.1. By Drug Type

        18.3.2. By Indication

        18.3.3. By Route of Administration

        18.3.4. By Schedule of Drug

        18.3.5. By Distribution Channel

        18.3.6. By Country

            18.3.6.1. Australia

            18.3.6.2. New Zealand

    18.4. Market Attractiveness Analysis

        18.4.1. By Drug Type

        18.4.2. By Indication

        18.4.3. By Route of Administration

        18.4.4. By Schedule of Drug

        18.4.5. By Distribution Channel

        18.4.6. By Country

    18.5. Market Trends

19. Middle East and Africa Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030

        19.3.1. By Drug Type

        19.3.2. By Indication

        19.3.3. By Route of Administration

        19.3.4. By Schedule of Drug

        19.3.5. By Distribution Channel

        19.3.6. By Country

            19.3.6.1. GCC Countries

            19.3.6.2. Turkey

            19.3.6.3. Northern Africa

            19.3.6.4. South Africa

            19.3.6.5. Rest of Middle East and Africa

    19.4. Market Attractiveness Analysis

        19.4.1. By Drug Type

        19.4.2. By Indication

        19.4.3. By Route of Administration

        19.4.4. By Schedule of Drug

        19.4.5. By Distribution Channel

        19.4.6. By Country

    19.5. Market Trends

20. Key and Emerging Countries Vaginitis Treatment Drugs Market Analysis

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. U.S. Vaginitis Treatment Drugs Market Analysis

        20.2.1. By Drug Type

        20.2.2. By Indication

        20.2.3. By Route of Administration

        20.2.4. By Schedule of Drug

        20.2.5. By Distribution Channel

    20.3. Canada Vaginitis Treatment Drugs Market Analysis

        20.3.1. By Drug Type

        20.3.2. By Indication

        20.3.3. By Route of Administration

        20.3.4. By Schedule of Drug

        20.3.5. By Distribution Channel

    20.4. Mexico Vaginitis Treatment Drugs Market Analysis

        20.4.1. By Drug Type

        20.4.2. By Indication

        20.4.3. By Route of Administration

        20.4.4. By Schedule of Drug

        20.4.5. By Distribution Channel

    20.5. Brazil Vaginitis Treatment Drugs Market Analysis

        20.5.1. By Drug Type

        20.5.2. By Indication

        20.5.3. By Route of Administration

        20.5.4. By Schedule of Drug

        20.5.5. By Distribution Channel

    20.6. Germany Vaginitis Treatment Drugs Market Analysis

        20.6.1. By Drug Type

        20.6.2. By Indication

        20.6.3. By Route of Administration

        20.6.4. By Schedule of Drug

        20.6.5. By Distribution Channel

    20.7. Italy Vaginitis Treatment Drugs Market Analysis

        20.7.1. By Drug Type

        20.7.2. By Indication

        20.7.3. By Route of Administration

        20.7.4. By Schedule of Drug

        20.7.5. By Distribution Channel

    20.8. France Vaginitis Treatment Drugs Market Analysis

        20.8.1. By Drug Type

        20.8.2. By Indication

        20.8.3. By Route of Administration

        20.8.4. By Schedule of Drug

        20.8.5. By Distribution Channel

    20.9. U.K. Vaginitis Treatment Drugs Market Analysis

        20.9.1. By Drug Type

        20.9.2. By Indication

        20.9.3. By Route of Administration

        20.9.4. By Schedule of Drug

        20.9.5. By Distribution Channel

    20.10. Spain Vaginitis Treatment Drugs Market Analysis

        20.10.1. By Drug Type

        20.10.2. By Indication

        20.10.3. By Route of Administration

        20.10.4. By Schedule of Drug

        20.10.5. By Distribution Channel

    20.11. Russia Vaginitis Treatment Drugs Market Analysis

        20.11.1. By Drug Type

        20.11.2. By Indication

        20.11.3. By Route of Administration

        20.11.4. By Schedule of Drug

        20.11.5. By Distribution Channel

    20.12. China Vaginitis Treatment Drugs Market Analysis

        20.12.1. By Drug Type

        20.12.2. By Indication

        20.12.3. By Route of Administration

        20.12.4. By Schedule of Drug

        20.12.5. By Distribution Channel

    20.13. Japan Vaginitis Treatment Drugs Market Analysis

        20.13.1. By Drug Type

        20.13.2. By Indication

        20.13.3. By Route of Administration

        20.13.4. By Schedule of Drug

        20.13.5. By Distribution Channel

    20.14. South Korea Vaginitis Treatment Drugs Market Analysis

        20.14.1. By Drug Type

        20.14.2. By Indication

        20.14.3. By Route of Administration

        20.14.4. By Schedule of Drug

        20.14.5. By Distribution Channel

    20.15. India Vaginitis Treatment Drugs Market Analysis

        20.15.1. By Drug Type

        20.15.2. By Indication

        20.15.3. By Route of Administration

        20.15.4. By Schedule of Drug

        20.15.5. By Distribution Channel

    20.16. Australia Vaginitis Treatment Drugs Market Analysis

        20.16.1. By Drug Type

        20.16.2. By Indication

        20.16.3. By Route of Administration

        20.16.4. By Schedule of Drug

        20.16.5. By Distribution Channel

    20.17. New Zealand Vaginitis Treatment Drugs Market Analysis

        20.17.1. By Drug Type

        20.17.2. By Indication

        20.17.3. By Route of Administration

        20.17.4. By Schedule of Drug

        20.17.5. By Distribution Channel

    20.18. GCC Countries Vaginitis Treatment Drugs Market Analysis

        20.18.1. By Drug Type

        20.18.2. By Indication

        20.18.3. By Route of Administration

        20.18.4. By Schedule of Drug

        20.18.5. By Distribution Channel

    20.19. Turkey Vaginitis Treatment Drugs Market Analysis

        20.19.1. By Drug Type

        20.19.2. By Indication

        20.19.3. By Route of Administration

        20.19.4. By Schedule of Drug

        20.19.5. By Distribution Channel

    20.20. South Africa Vaginitis Treatment Drugs Market Analysis

        20.20.1. By Drug Type

        20.20.2. By Indication

        20.20.3. By Route of Administration

        20.20.4. By Schedule of Drug

        20.20.5. By Distribution Channel

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Concentration

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Deep Dive

        22.2.1. Abbott Laboratories

        22.2.2. Baxter International Inc.

        22.2.3. B. Braun Melsungen AG

        22.2.4. Allergan AG

        22.2.5. Johnson & Johnson

        22.2.6. Prestige Consumer Healthcare, Inc.

        22.2.7. Sanofi SA

        22.2.8. Merck & Co Inc.

        22.2.9.  Aurobindo Pharma Limited

        22.2.10. Mylan NV

        22.2.11. Sun Pharmaceutical Industries Limited

        22.2.12. Pfizer Inc.

        22.2.13. Teva Pharmaceutical Industries Ltd

        22.2.14. Bayer AG

        22.2.15. Dr. Reddy's Laboratories Ltd

        22.2.16. Novartis International AG

        22.2.17. Cipla Ltd.

        22.2.18.  Bausch & Lomb Incorporated

        22.2.19. Galderma S.A.

        22.2.20. Bristol Myers Squibb Company

        22.2.21. Perrigo Company plc.

        22.2.22. Lupin Pharmaceuticals, Inc.

        22.2.23. Glenmark Pharmaceuticals Inc.

        22.2.24. Eurofins Scientific SE

        22.2.25. Apotex Inc.

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type

Table 02: Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 , By Indication

Table 03: Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration

Table 04: Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug

Table 05: Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel

Table 06: Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, By Region

Table 07: North America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country

Table 08: North America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type

Table 09: North America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication

Table 10: North America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration

Table 11: North America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug

Table 12: North America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel

Table 13: Latin America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country

Table 14: Latin America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type

Table 15: Latin America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication

Table 16: Latin America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration

Table 17: Latin America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug

Table 18: Latin America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel

Table 19: Europe Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country

Table 20: Europe Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type

Table 21: Europe Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication

Table 22: Europe Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration

Table 23: Europe Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug

Table 24: Europe Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel

Table 25: South Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country

Table 26: South Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type

Table 27: South Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication

Table 28: South Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration

Table 29: South Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug

Table 30: South Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel

Table 31: East Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country

Table 32: East Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type

Table 33: East Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication

Table 34: East Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration

Table 35: East Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug

Table 36: East Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel

Table 37: Oceania Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country

Table 38: Oceania Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type

Table 39: Oceania Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication

Table 40: Oceania Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration

Table 41: Oceania Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug

Table 42: Oceania Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel

Table 43: Middle East & Africa Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country

Table 44: Middle East & Africa Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type

Table 45: Middle East & Africa Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication

Table 46: Middle East & Africa Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration

Table 47: Middle East & Africa Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug

Table 48: Middle East & Africa Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01: Global Vaginitis Treatment Drugs Market Value Analysis, 2015–2021

Figure 02: Global Vaginitis Treatment Drugs Market Forecast & Y-o-Y Growth, 2022–2030

Figure 03: Global Vaginitis Treatment Drugs Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2030

Figure 04: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis, 2021–2030

Figure 05: Global Vaginitis Treatment Drugs Market Value Share (%) Analysis 2022 & 2030, By Drug Type

Figure 06: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis 2021-2030, By Drug Type

Figure 07: Global Vaginitis Treatment Drugs Market Attractiveness Analysis 2022–2030 , By Drug Type

Figure 08: Global Vaginitis Treatment Drugs Market Value Share (%) Analysis 2022 & 2030, By Indication

Figure 09: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis 2021-2030, By Indication

Figure 10: Global Vaginitis Treatment Drugs Market Attractiveness Analysis 2022–2030 , By Indication

Figure 11: Global Vaginitis Treatment Drugs Market Value Share (%) Analysis 2022 & 2030, By Route of Administration

Figure 12: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis 2021-2030, By Route of Administration

Figure 13: Global Vaginitis Treatment Drugs Market Attractiveness Analysis 2022–2030 , By Route of Administration

Figure 14: Global Vaginitis Treatment Drugs Market Value Share (%) Analysis 2022 & 2030, By Schedule of Drug

Figure 15: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis 2021-2030, By Schedule of Drug

Figure 16: Global Vaginitis Treatment Drugs Market Attractiveness Analysis 2022–2030 , By Schedule of Drug

Figure 17: Global Vaginitis Treatment Drugs Market Value Share (%) Analysis 2022 & 2030, By Distribution Channel

Figure 18: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis 2021-2030, By Distribution Channel

Figure 19: Global Vaginitis Treatment Drugs Market Attractiveness Analysis 2022–2030 , By Distribution Channel

Figure 20: Global Vaginitis Treatment Drugs Market Value Share (%) Analysis 2022 & 2030, By Region

Figure 21: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis 2021-2030, By Region

Figure 22: Global Vaginitis Treatment Drugs Market Attractiveness Analysis 2022–2030 , By Region

Figure 23: North America Vaginitis Treatment Drugs Market Value Analysis, 2015–2021

Figure 24: North America Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030

Figure 25: North America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type

Figure 26: North America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication

Figure 27: North America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration

Figure 28: North America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug

Figure 29: North America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel

Figure 30: North America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country

Figure 31: Latin America Vaginitis Treatment Drugs Market Value Analysis, 2015–2021

Figure 32: Latin America Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030

Figure 33: Latin America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type

Figure 34: Latin America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication

Figure 35: Latin America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration

Figure 36: Latin America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug

Figure 37: Latin America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel

Figure 38: Latin America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country

Figure 39: Europe Vaginitis Treatment Drugs Market Value Analysis, 2015–2021

Figure 40: Europe Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030

Figure 41: Europe Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type

Figure 42: Europe Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication

Figure 43: Europe Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration

Figure 44: Europe Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug

Figure 45: Europe Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel

Figure 46: Europe Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country

Figure 47: South Asia Vaginitis Treatment Drugs Market Value Analysis, 2015–2021

Figure 48: South Asia Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030

Figure 49: South Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type

Figure 50: South Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication

Figure 51: South Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration

Figure 52: South Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug

Figure 53: South Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel

Figure 54: South Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country

Figure 55: East Asia Vaginitis Treatment Drugs Market Value Analysis, 2015–2021

Figure 56: East Asia Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030

Figure 57: East Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type

Figure 58: East Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication

Figure 59: East Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration

Figure 60: East Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug

Figure 61: East Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel

Figure 62: East Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country

Figure 63: Oceania Vaginitis Treatment Drugs Market Value Analysis, 2015–2021

Figure 64: Oceania Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030

Figure 65: Oceania Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type

Figure 66: Oceania Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication

Figure 67: Oceania Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration

Figure 68: Oceania Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug

Figure 69: Oceania Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel

Figure 70: Oceania Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country

Figure 71: Middle East & Africa Vaginitis Treatment Drugs Market Value Analysis, 2015–2021

Figure 72: Middle East & Africa Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030

Figure 73: Middle East & Africa Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type

Figure 74: Middle East & Africa Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication

Figure 75: Middle East & Africa Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration

Figure 76: Middle East & Africa Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug

Figure 77: Middle East & Africa Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel

Figure 78: Middle East & Africa Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country

Figure 79: U.S. Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 80: U.S. Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 81: U.S. Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 82: U.S. Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 83: U.S. Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 84: Canada Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 85: Canada Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 86: Canada Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 87: Canada Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 88: Canada Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 89: Mexico Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 90: Mexico Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 91: Mexico Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 92: Mexico Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 93: Mexico Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 94: Brazil Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 95: Brazil Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 96: Brazil Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 97: Brazil Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 98: Brazil Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 99: U.K. Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 100: U.K. Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 101: U.K. Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 102: U.K. Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 103: U.K. Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 104: Germany Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 105: Germany Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 106: Germany Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 107: Germany Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 108: Germany Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 109: France Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 110: France Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 111: France Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 112: France Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 113: France Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 114: Italy Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 115: Italy Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 116: Italy Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 117: Italy Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 118: Italy Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 119: Spain Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 120: Spain Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 121: Spain Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 122: Spain Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 123: Spain Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 124: Russia Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 125: Russia Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 126: Russia Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 127: Russia Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 128: Russia Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 129: China Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 130: China Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 131: China Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 132: China Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 133: China Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 134: Japan Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 135: Japan Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 136: Japan Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 137: Japan Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 138: Japan Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 139: South Korea Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 140: South Korea Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 141: South Korea Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 142: South Korea Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 143: South Korea Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 144: India Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 145: India Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 146: India Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 147: India Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 148: India Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 149: Australia Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 150: Australia Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 151: Australia Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 152: Australia Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 153: Australia Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 154: New Zealand Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 155: New Zealand Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 156: New Zealand Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 157: New Zealand Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 158: New Zealand Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 159: GCC Countries Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 160: GCC Countries Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 161: GCC Countries Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 162: GCC Countries Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 163: GCC Countries Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 164: Turkey Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 165: Turkey Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 166: Turkey Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 167: Turkey Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 168: Turkey Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Figure 169: South Africa Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A

Figure 170: South Africa Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A

Figure 171: South Africa Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A

Figure 172: South Africa Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A

Figure 173: South Africa Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Vaginitis Treatment Drugs Market

Published : July 2020

Healthcare

Preterm Birth Diagnostic Test Kits Market

Published : December 2021

Healthcare

Soft Tissue Repair Market

Published : September 2017

Healthcare

Female Pelvic Implants Market

Published : July 2021

Google translate

Vaginitis Treatment Drugs Market